2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American college of cardiology/American heart association task force on practice guidelines

TY - JOUR

T1 - 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery

T2 - A report of the American college of cardiology/American heart association task force on practice guidelines

AU - Fleisher, Lee A.

AU - Fleischmann, Kirsten E.

AU - Auerbach, Andrew D.

AU - Barnason, Susan Ann

AU - Beckman, Joshua A.

AU - Bozkurt, Biykem

AU - Davila-Roman, Victor G.

AU - Gerhard-Herman, Marie D.

AU - Holly, Thomas A.

AU - Kane, Garvan C.

AU - Marine, Joseph E.

AU - Nelson, M. Timothy

AU - Spencer, Crystal C.

AU - Thompson, Annemarie

AU - Ting, Henry H.

AU - Uretsky, Barry F.

AU - Wijeysundera, Duminda N.

N1 - Funding Information: Reviewer Representation Employment Consultant Speakers Bureau Ownership/Partnership/Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Kim Eagle Official Reviewer—AHA University of Michigan Health System—Albion Walter Hewlett Professor of Internal Medicine None None None • GORE • Medtronic None None Dipti Itchhaporia Official Reviewer—ACC Board of Trustees Hoag Memorial Hospital Presbyterian—Robert and Georgia Roth Chair for Excellence in Cardiac Care; Director of Disease Management None None None None None None Mary Lough Official Reviewer—AHA Stanford Hospital and Clinics—Critical Care Clinical Nurse Specialist None None None None None None G. B. John Mancini Official Reviewer—ACC Board of Governors Vancouver Hospital Research Pavilion—Professor of Medicine • Merck • Pfizer • Servier None None • Merck ∗ • Miraculins ∗ None Frank W. Sellke Official Reviewer—ACC/AHA Task Force on Practice Guidelines Brown Medical School, Rhode Island Hospital—Professor; Chief of Cardiothoracic Surgery None None None None • CSL Behring • The Medicines Company None Michael Baker Organizational Reviewer—ASE Vanderbilt University—Assistant Professor of Medicine None None None None • Medtronic † None Michael England Organizational Reviewer—ASA Tufts University School of Medicine—Division Chief, Cardiac Anesthesiology; Assistant Professor None • Hospira None None None None Leonard Feldman Organizational Reviewer—SHM Johns Hopkins School of Medicine–Director, Medicine-Pediatrics Urban Health Residency Program; Assistant Professor of Pediatrics; Assistant Professor of Medicine None None None None None • Defendant, pulmonary embolism, 2013 • Defendant, aortic dissection, 2013 • Defendant, stroke, 2013 • Defendant, sudden cardiac death, 2013 Jason Kovacic Organizational Reviewer—SCAI Mount Sinai School of Medicine—Assistant Professor of Medicine • AstraZeneca ∗ • AstraZeneca None None None None Martin London Organizational Reviewer—SCA University of California, San Francisco Medical Center—Professor of Clinical Anesthesia None None None None None None Rupa Mehta Sanghani Organizational Reviewer—ASNC University of Chicago Medicine—Director, Cardiac Rehabilitation; Assistant Professor of Medicine • Astellas • Astellas None None None None Reena Pande Organizational Reviewer—SVM Brigham and Women’s Hospital, Prevention Brigham and Women’s Hospital—Associate Physician; Harvard Medical School, Professor None None None None None None Jeanne Poole Organizational Reviewer—HRS University of Washington—Professor of Medicine, Division of Cardiology • Biotronik • Boston Scientific ∗ • Medtronic • St. Jude Medical None None None • Boston Scientific • Medtronic None Russell Postier Organizational Reviewer—ACS University of Oklahoma Health Sciences Center—John A. Schilling Professor and Chairman, Department of Surgery None None None None None None M. Obadah N. Al-Chekakie Content Reviewer—ACC Board of Governors Cheyenne Regional Medical Group—Physician None None None None None None Jeffrey L. Anderson Content Reviewer—ACC/AHA Task Force on Practice Guidelines Intermountain Medical Center—Associate Chief of Cardiology • Sanofi-aventis • The Medicines Company None None None None None H. Vernon Anderson Content Reviewer—ACC Interventional Section Leadership Council University of Texas Cardiology Division—Professor of Medicine None None None None • MedPlace Medical Devices (DSMB) None Hugh Calkins Content Reviewer Johns Hopkins Hospital—Professor of Medicine; Director of Electrophysiology None None None • St. Jude Medical ∗ None None Steven Cohn Content Reviewer University of Miami—Professor of Clinical Medicine; University of Miami Hospital—Director, Medical Consultation Service; University Health Preoperative Assessment Center—Medical Director None None • AstraZeneca ∗ • Bristol-Myers Squibb ∗ • GlaxoSmithKline ∗ • Merck ∗ • Pfizer ∗ None None • Defendant, venous thromboemboli pulmonary embolism, 2013 • Defendant, preoperative evaluation, 2013 George Crossley Content Reviewer—ACC Electrophysiology Section Leadership Council St. Thomas Heart—Medical Director, Cardiac Services • Boston Scientific • Medtronic ∗ • Medtronic ∗ • Sanofi-aventis None None None • Defendant, pacemaker complication, 2012 • Defendant, EP procedure complication, 2013 P.J. Devereaux Content Reviewer McMaster University—Associate Professor, Departments of Clinical Epidemiology and Biostatistics; Juravinski Hospital and Cancer Centre—Head of Cardiology and the Perioperative Cardiovascular Service None None None • Abbott Diagnostics ∗ • Bayer ∗ • Boehringer Ingelheim ∗ • Roche Diagnostics ∗ • Stryker ∗ • Canadian Perioperative Guideline Chair None Richard Lange Content Reviewer University of Texas Health Science Center at San Antonio—Professor of Medicine None None None None None None Maria Lantin-Hermoso Content Reviewer—ACC Congenital and Pediatric Cardiology Section Leadership Council Baylor College of Medicine—Associate Professor, Department of Pediatrics, Section of Cardiology; Texas Children’s Hospital— Attending Physician None None None None None None Srinivas Murali Content Reviewer—ACC Board of Governors Temple University School of Medicine— Professor of Medicine; Director, Division of Cardiovascular Medicine; Cardiovascular Institute Medical—Medical director • Actelion • Bayer • Gilead • Lung Biotechnology • Actelion None • Cardiokinetics • CVRx • Gilead • Ikaria • Medtronic • St. Jude Medical None None E. Magnus Ohman Content Reviewer—ACC/AHA Task Force on Practice Guidelines Duke University Medical Center—Professor of Medicine; Director, Program for Advanced Coronary Disease • Abiomed ∗ • AstraZeneca • Daiichi-Sankyo ∗ • Gilead Sciences • Janssen Pharmaceuticals ∗ • Pozen • Sanofi-aventis ∗ • The Medicines Company None None • Eli Lilly ∗ • Gilead Sciences ∗ None None Gurusher Panjrath Content Reviewer—ACC Heart Failure and Transplant Section Leadership Council George Washington Heart and Vascular Institute—Assistant Professor of Medicine; Director, Heart Failure and Mechanical Support Program None None None None None None Susan J. Pressler Content Reviewer—ACC/AHA Task Force on Practice Guidelines University of Michigan School of Nursing—Professor None None None None • Pfizer † None Pasala Ravichandran Content Reviewer—ACC Surgeons’ Council Oregon Health and Science University—Associate Professor None None None None None None Ezra Amsterdam Content Reviewer University of California Davis Medical Center Division of Cardiology—Professor None None None None None None John Erwin Content Reviewer Scott and White Hospital and Clinic—Senior Staff Cardiologist, Associate Professor of Medicine None None None • Eli Lilly (PI) ∗ None None Samuel Gidding Content Reviewer—ACC/AHA Task Force on Practice Guidelines Nemours/Alfred I. DuPont Hospital for Children—Chief, Division of Pediatric Cardiology None None None • GlaxoSmithKline ∗ None None Robert Hendel Content Reviewer University of Miami School of Medicine—Director Cardiac Imaging and Outpatient Services • Adenosine Therapeutics • Astellas • Bayer None None None None None Glenn Levine Content Reviewer Baylor College of Medicine—Associate Professor of Medicine None None None None None None Karen Mauck Content Reviewer Mayo Clinic Minnesota—Associate Professor of Medicine None None None None None None Win-Kuang Shen Content Reviewer—ACC/AHA Task Force on Practice Guidelines Mayo Clinic Arizona—Professor of Medicine None None None None None None Ralph Verdino Content Reviewer Hospital of the University of Pennsylvania—Associate Professor of Medicine; Director, Cardiology Electrophysiology Fellowship Program • Biotronik • Medtronic • St. Jude Medical ∗ None None None • LifeWatch ∗ None L. Samuel Wann Content Reviewer Columbia St. Mary’s Cardiovascular Physicians—Clinical Cardiologist None None None None None None Clyde W. Yancy Content Reviewer Northwestern University, Feinberg School of Medicine—Magerstadt Professor of Medicine; Chief, Division of Cardiology None None None None None None This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant to this document. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document ; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document , or makes a competing drug or device addressed in the document ; or c) the person or a member of the person’s household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document . ACC indicates American College of Cardiology; ACS, American College of Surgeons; AHA, American Heart Association; ASA, American Society of Anesthesiologists; ASE, American Society of Echocardiography; ASNC, American Society of Nuclear Cardiology; DSMB, data safety monitoring board; EP, electrophysiology; HRS, Heart Rhythm Society; PI, principal investigator; SCA, Society of Cardiovascular Anesthesiologists; SCAI, Society for Cardiovascular Angiography and Interventions; SHM, Society of Hospital Medicine; and SVM, Society for Vascular Medicine. ∗ Significant relationship. † No financial benefit. Appendix 3

PY - 2014/12/9

Y1 - 2014/12/9

KW - ACC/AHA Clinical Practice Guideline

KW - adrenergic beta-antagonists

KW - anesthesia and analgesia

KW - diagnostic techniques cardiovascular

KW - monitoring intraoperative

KW - perioperative care

KW - platelet aggregation inhibitors

KW - referral and consultation

KW - troponin

UR - http://www.scopus.com/inward/record.url?scp=84914108635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914108635&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2014.07.944

DO - 10.1016/j.jacc.2014.07.944

M3 - Article

C2 - 25091544

AN - SCOPUS:84914108635

VL - 64

SP - e77-e137

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 22

ER -